Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Scott Devoll Cramer

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PHARM General Operations
Phone303/724-6276

    Collapse Research 
    Collapse research activities and funding
    R01CA262279     (CRAMER, SCOTT D)Jul 1, 2021 - Jun 30, 2026
    NIH
    Androgen Signaling in CaP with loss of MAP3K7 and CHD1
    Role: Principal Investigator
    U01CA231978     (COSTELLO, JAMES CHRISTOPHER ;CRAMER, SCOTT D)Sep 1, 2019 - Aug 31, 2024
    NIH
    Systems analysis of aggressive prostate cancer pathology
    Role: Co-Principal Investigator
    T32CA190216     (REYLAND, MARY ELAINE)Jul 7, 2016 - Jul 31, 2027
    NIH
    Training Program in Cancer Biology
    Role: Principal Investigator
    R21CA197887     (THORBURN, ANDREW M)Apr 1, 2016 - Mar 31, 2018
    NIH
    Autophagy regulation of prostate tumor development
    Role: Principal Investigator
    R01CA199741     (CRAMER, SCOTT D)Jun 15, 2015 - May 31, 2020
    NIH
    CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
    Role: Principal Investigator
    R21CA187354     (CRAMER, SCOTT D)Apr 6, 2015 - Mar 31, 2018
    NIH
    CHD1 and TAK1 Synthetic Lethality in Prostate Cancer
    Role: Principal Investigator
    R21CA173092     (DAVALOS, RAFAEL VIDAL)Sep 19, 2012 - Aug 31, 2015
    NIH
    Isolation of Tumor Initiating Cells (TICs) using Contactless Dielectrophoresis
    Role: Co-Principal Investigator
    R01CA150105     (CRAMER, SCOTT D)Jul 6, 2010 - May 31, 2016
    NIH
    The prostate stem cell is a target of vitamin D chemoprevention
    Role: Principal Investigator
    R01CA129418     (CRAMER, SCOTT D)Jul 1, 2009 - Apr 30, 2015
    NIH
    Tak1, a novel prostate cancer tumor suppressor
    Role: Principal Investigator
    R21DK069331     (CRAMER, SCOTT D)Mar 1, 2005 - Feb 28, 2008
    NIH
    Mitochondrial GRHPR and Hyperoxaluria
    Role: Principal Investigator
    R01CA101023     (CRAMER, SCOTT D)Sep 30, 2004 - Jun 30, 2010
    NIH
    Vitamin D and Soy Isoflavone Inhibition of Prostate
    Role: Principal Investigator
    R21CA108625     (CRAMER, SCOTT D)Aug 23, 2004 - Jul 31, 2007
    NIH
    Prostate Specific Antigen and Prostate Ca. Progression
    Role: Principal Investigator
    R21DK060480     (CRAMER, SCOTT D)Mar 15, 2002 - Dec 31, 2004
    NIH
    GPHRP KNOCKOUT MOUSE AS A MODEL OF HYPEROXALURIA
    Role: Principal Investigator
    R29DK052623     (CRAMER, SCOTT D)Jul 7, 1997 - May 31, 2002
    NIH
    PTHRP AND PROSTATE GROWTH
    Role: Principal Investigator
    F32CA059086     (CRAMER, SCOTT D)Feb 1, 1993
    NIH
    VITAMIN D AND PROSTATE CANCER
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gillette CM, Yette GA, Cramer SD, Graham LS. Management of Advanced Prostate Cancer in the Precision Oncology Era. Cancers (Basel). 2023 Apr 29; 15(9). PMID: 37174018.
      View in: PubMed
    2. Furnish M, Boulton DP, Genther V, Grofova D, Ellinwood ML, Romero L, Lucia MS, Cramer SD, Caino MC. MIRO2 Regulates Prostate Cancer Cell Growth via GCN1-Dependent Stress Signaling. Mol Cancer Res. 2022 04 01; 20(4):607-621. PMID: 34992146.
      View in: PubMed
    3. Jillson LK, Yette GA, Laajala TD, Tilley WD, Costello JC, Cramer SD. Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes. Cancers (Basel). 2021 Jun 30; 13(13). PMID: 34208794.
      View in: PubMed
    4. Jillson LK, Rider LC, Rodrigues LU, Romero L, Karimpour-Fard A, Nieto C, Gillette C, Torkko K, Danis E, Smith EE, Nolley R, Peehl DM, Lucia MS, Costello JC, Cramer SD. MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1. Mol Cancer Res. 2021 07; 19(7):1123-1136. PMID: 33846123.
      View in: PubMed
    5. Bayne RS, Puckett S, Rodrigues LU, Cramer SD, Lee J, Furdui CM, Chou JW, Miller LD, Ornelles DA, Lyles DS. MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells. Mol Ther Oncolytics. 2020 Jun 26; 17:496-507. PMID: 32529027.
      View in: PubMed
    6. Miller DR, Cramer SD, Thorburn A. The interplay of autophagy and non-apoptotic cell death pathways. Int Rev Cell Mol Biol. 2020; 352:159-187. PMID: 32334815.
      View in: PubMed
    7. Washino S, Rider LC, Romero L, Jillson LK, Affandi T, Ohm AM, Lam ET, Reyland ME, Costello JC, Cramer SD. Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination. Mol Cancer Res. 2019 10; 17(10):1985-1998. PMID: 31300540.
      View in: PubMed
    8. Ormond DR, Kleinschmidt-DeMasters BK, Cavalcante D, Smith EE, Cramer SD, Lucia MS. Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expression. J Neurooncol. 2019 Apr; 142(2):319-325. PMID: 30656528.
      View in: PubMed
    9. Chmielewski JP, Bowlby SC, Wheeler FB, Shi L, Sui G, Davis AL, Howard TD, D'Agostino RB, Miller LD, Sirintrapun SJ, Cramer SD, Kridel SJ. CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools. Mol Cancer Res. 2018 11; 16(11):1687-1700. PMID: 30076241.
      View in: PubMed
    10. Goodall ML, Cramer SD, Thorburn A. Autophagy RIPs into cell death. Cell Cycle. 2016 11 16; 15(22):3014-3015. PMID: 27574850.
      View in: PubMed
    11. Goodall ML, Cramer SD, Thorburn A. Autophagy complexes cell death by necroptosis. Oncotarget. 2016 08 09; 7(32):50818-50819. PMID: 27449298.
      View in: PubMed
    12. Goodall ML, Fitzwalter BE, Zahedi S, Wu M, Rodriguez D, Mulcahy-Levy JM, Green DR, Morgan M, Cramer SD, Thorburn A. The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis. Dev Cell. 2016 May 23; 37(4):337-349. PMID: 27219062.
      View in: PubMed
    13. Rider L, Cramer SD. SPOP the mutation. Elife. 2015 Oct 27; 4. PMID: 26506153.
      View in: PubMed
    14. Mandell E, Seedorf GJ, Ryan S, Gien J, Cramer SD, Abman SH. Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1a-hydroxylase expression in the developing rat. Am J Physiol Lung Cell Mol Physiol. 2015 Nov 01; 309(9):L1018-26. PMID: 26342089.
      View in: PubMed
    15. Schlaepfer IR, Glod? LM, Hitz CA, Pac CT, Boyle KE, Maroni P, Deep G, Agarwal R, Lucia SM, Cramer SD, Serkova NJ, Eckel RH. Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts. Mol Imaging Biol. 2015 Aug; 17(4):529-38. PMID: 25561013.
      View in: PubMed
    16. Rodrigues LU, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, Lucia MS, Wu M, Shi L, Cimic A, Sirintrapun SJ, Nolley R, Pac C, Chen H, Peehl DM, Xu J, Liu W, Costello JC, Cramer SD. Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. Cancer Res. 2015 Mar 15; 75(6):1021-34. PMID: 25770290.
      View in: PubMed
    17. Yu N, Puckett S, Antinozzi PA, Cramer SD, Lyles DS. Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer. J Virol. 2015 May; 89(10):5250-63. PMID: 25741004.
      View in: PubMed
    18. Schlaepfer IR, Rider L, Rodrigues LU, Gij?n MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glod? LM, Eckel RH, Cramer SD. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol Cancer Ther. 2014 Oct; 13(10):2361-71. PMID: 25122071.
      View in: PubMed
    19. Nieto CM, Rider LC, Cramer SD. Influence of stromal-epithelial interactions on androgen action. Endocr Relat Cancer. 2014 Aug; 21(4):T147-60. PMID: 24872510.
      View in: PubMed
    20. Ting HJ, Deep G, Jain AK, Cimic A, Sirintrapun J, Romero LM, Cramer SD, Agarwal C, Agarwal R. Silibinin prevents prostate cancer cell-mediated differentiation of na?ve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF ?2. Mol Carcinog. 2015 Sep; 54(9):730-41. PMID: 24615813.
      View in: PubMed
    21. Maund SL, Shi L, Cramer SD. A role for interleukin-1 alpha in the 1,25 dihydroxyvitamin D3 response in mammary epithelial cells. PLoS One. 2013; 8(11):e81367. PMID: 24244740.
      View in: PubMed
    22. Liu W, Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, Wang Z, Zhang Z, Sun J, Sun J, Koty PP, Kader AK, Cramer SD, Bova GS, Zheng SL, Gr?nberg H, Isaacs WB, Xu J. Genetic markers associated with early cancer-specific mortality following prostatectomy. Cancer. 2013 Jul 01; 119(13):2405-12. PMID: 23609948.
      View in: PubMed
    23. Wu M, Shi L, Cimic A, Romero L, Sui G, Lees CJ, Cline JM, Seals DF, Sirintrapun JS, McCoy TP, Liu W, Kim JW, Hawkins GA, Peehl DM, Xu J, Cramer SD. Suppression of Tak1 promotes prostate tumorigenesis. Cancer Res. 2012 Jun 01; 72(11):2833-43. PMID: 22467172.
      View in: PubMed
    24. Knight J, Holmes RP, Cramer SD, Takayama T, Salido E. Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol Renal Physiol. 2012 Mar 15; 302(6):F688-93. PMID: 22189945.
      View in: PubMed
    25. Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, Cramer SD, Thomas MJ, Perry DL, Edwards IJ, Mucci LA, Sinnott JA, Loda MF, Sui G, Berquin IM, Chen YQ. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Carcinogenesis. 2012 Feb; 33(2):404-12. PMID: 22159221.
      View in: PubMed
    26. Liu W, Lindberg J, Sui G, Luo J, Egevad L, Li T, Xie C, Wan M, Kim ST, Wang Z, Turner AR, Zhang Z, Feng J, Yan Y, Sun J, Bova GS, Ewing CM, Yan G, Gielzak M, Cramer SD, Vessella RL, Zheng SL, Gr?nberg H, Isaacs WB, Xu J. Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene. 2012 Aug 30; 31(35):3939-48. PMID: 22139082.
      View in: PubMed
    27. Salmanzadeh A, Romero L, Shafiee H, Gallo-Villanueva RC, Stremler MA, Cramer SD, Davalos RV. Isolation of prostate tumor initiating cells (TICs) through their dielectrophoretic signature. Lab Chip. 2012 Jan 07; 12(1):182-9. PMID: 22068834.
      View in: PubMed
    28. Maund SL, Barclay WW, Hover LD, Axanova LS, Sui G, Hipp JD, Fleet JC, Thorburn A, Cramer SD. Interleukin-1a mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells. Cancer Res. 2011 Aug 01; 71(15):5276-86. PMID: 21653679.
      View in: PubMed
    29. Maund SL, Cramer SD. The tissue-specific stem cell as a target for chemoprevention. Stem Cell Rev Rep. 2011 Jun; 7(2):307-14. PMID: 21086069.
      View in: PubMed
    30. Maund SL, Cramer SD. Pancreatic cancer with Nest-in tendencies. Cancer Biol Ther. 2011 Mar 15; 11(6):559-61. PMID: 21266845.
      View in: PubMed
    31. Axanova LS, Chen YQ, McCoy T, Sui G, Cramer SD. 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. Prostate. 2010 Nov 01; 70(15):1658-71. PMID: 20583132.
      View in: PubMed
    32. Cen B, Mahajan S, Zemskova M, Beharry Z, Lin YW, Cramer SD, Lilly MB, Kraft AS. Regulation of Skp2 levels by the Pim-1 protein kinase. J Biol Chem. 2010 Sep 17; 285(38):29128-37. PMID: 20663873.
      View in: PubMed
    33. Cao P, Deng Z, Wan M, Huang W, Cramer SD, Xu J, Lei M, Sui G. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer. 2010 May 17; 9:108. PMID: 20478051.
      View in: PubMed
    34. Deng Z, Wan M, Cao P, Rao A, Cramer SD, Sui G. Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene. 2009 Oct 22; 28(42):3746-57. PMID: 19668226.
      View in: PubMed
    35. Levin-Iaina N, Dinour D, Romero L, Ron R, Brady RL, Cramer SD, Holtzman EJ. Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling. J Urol. 2009 May; 181(5):2146-51. PMID: 19296982.
      View in: PubMed
    36. Wiklund F, Zheng SL, Sun J, Adami HO, Lilja H, Hsu FC, Stattin P, Adolfsson J, Cramer SD, Duggan D, Carpten JD, Chang BL, Isaacs WB, Gr?nberg H, Xu J. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate. 2009 Mar 01; 69(4):419-27. PMID: 19116992.
      View in: PubMed
    37. Chang BL, Cramer SD, Wiklund F, Isaacs SD, Stevens VL, Sun J, Smith S, Pruett K, Romero LM, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Adolfsson J, Liu W, Kim JW, Duggan D, Carpten J, Zheng SL, Rodriguez C, Isaacs WB, Gr?nberg H, Xu J. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet. 2009 Apr 01; 18(7):1368-75. PMID: 19153072.
      View in: PubMed
    38. Cramer SD, Sun J, Zheng SL, Xu J, Peehl DM. Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2451-7. PMID: 18768516.
      View in: PubMed
    39. Barclay WW, Axanova LS, Chen W, Romero L, Maund SL, Soker S, Lees CJ, Cramer SD. Characterization of adult prostatic progenitor/stem cells exhibiting self-renewal and multilineage differentiation. Stem Cells. 2008 Mar; 26(3):600-10. PMID: 18055450.
      View in: PubMed
    40. Liu W, Chang BL, Cramer S, Koty PP, Li T, Sun J, Turner AR, Von Kap-Herr C, Bobby P, Rao J, Zheng SL, Isaacs WB, Xu J. Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers. Clin Cancer Res. 2007 Sep 01; 13(17):5028-33. PMID: 17785553.
      View in: PubMed
    41. Takayama T, Nagata M, Ozono S, Nonomura K, Cramer SD. A novel mutation in the GRHPR gene in a Japanese patient with primary hyperoxaluria type 2. Nephrol Dial Transplant. 2007 Aug; 22(8):2371-4. PMID: 17510093.
      View in: PubMed
    42. Knight J, Holmes RP, Milliner DS, Monico CG, Cramer SD. Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2. Nephrol Dial Transplant. 2006 Aug; 21(8):2292-5. PMID: 16597637.
      View in: PubMed
    43. O'Flaherty JT, Rogers LC, Paumi CM, Hantgan RR, Thomas LR, Clay CE, High K, Chen YQ, Willingham MC, Smitherman PK, Kute TE, Rao A, Cramer SD, Morrow CS. 5-Oxo-ETE analogs and the proliferation of cancer cells. Biochim Biophys Acta. 2005 Oct 01; 1736(3):228-36. PMID: 16154383.
      View in: PubMed
    44. Barclay WW, Cramer SD. Culture of mouse prostatic epithelial cells from genetically engineered mice. Prostate. 2005 May 15; 63(3):291-8. PMID: 15599944.
      View in: PubMed
    45. Wansley EK, Dillon PJ, Gainey MD, Tam J, Cramer SD, Parks GD. Growth sensitivity of a recombinant simian virus 5 P/V mutant to type I interferon differs between tumor cell lines and normal primary cells. Virology. 2005 Apr 25; 335(1):131-44. PMID: 15823612.
      View in: PubMed
    46. Dallas SL, Zhao S, Cramer SD, Chen Z, Peehl DM, Bonewald LF. Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen. J Cell Physiol. 2005 Feb; 202(2):361-70. PMID: 15389580.
      View in: PubMed
    47. Thorburn J, Moore F, Rao A, Barclay WW, Thomas LR, Grant KW, Cramer SD, Thorburn A. Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells. Mol Biol Cell. 2005 Mar; 16(3):1189-99. PMID: 15635090.
      View in: PubMed
    48. Ahmed M, Cramer SD, Lyles DS. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses. Virology. 2004 Dec 05; 330(1):34-49. PMID: 15527832.
      View in: PubMed
    49. Barclay WW, Woodruff RD, Hall MC, Cramer SD. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology. 2005 Jan; 146(1):13-8. PMID: 15471963.
      View in: PubMed
    50. Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res. 2004 Sep 01; 64(17):6344-8. PMID: 15342424.
      View in: PubMed
    51. Baker PR, Cramer SD, Kennedy M, Assimos DG, Holmes RP. Glycolate and glyoxylate metabolism in HepG2 cells. Am J Physiol Cell Physiol. 2004 Nov; 287(5):C1359-65. PMID: 15240345.
      View in: PubMed
    52. Rao A, Coan A, Welsh JE, Barclay WW, Koumenis C, Cramer SD. Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells. Cancer Res. 2004 Mar 15; 64(6):2143-7. PMID: 15026355.
      View in: PubMed
    53. Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP, Wang L, Burnstein KL, Holick MF, Koumenis C. Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3. Carcinogenesis. 2004 Jun; 25(6):1015-26. PMID: 14742320.
      View in: PubMed
    54. Dunlap N, Schwartz GG, Eads D, Cramer SD, Sherk AB, John V, Koumenis C. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells. Br J Cancer. 2003 Aug 18; 89(4):746-53. PMID: 12915889.
      View in: PubMed
    55. Cramer SD, Chang BL, Rao A, Hawkins GA, Zheng SL, Wade WN, Cooke RT, Thomas LN, Bleecker ER, Catalona WJ, Sterling DA, Meyers DA, Ohar J, Xu J. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J Natl Cancer Inst. 2003 Jul 16; 95(14):1044-53. PMID: 12865450.
      View in: PubMed
    56. Rao A, Chang BL, Hawkins G, Hu JJ, Rosser CJ, Hall MC, Meyers DA, Xu J, Cramer SD. Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms. Urology. 2003 Apr; 61(4):864-9. PMID: 12670590.
      View in: PubMed
    57. Wade WN, Willingham MC, Koumenis C, Cramer SD. p27Kip1 is essential for the antiproliferative action of 1,25-dihydroxyvitamin D3 in primary, but not immortalized, mouse embryonic fibroblasts. J Biol Chem. 2002 Oct 04; 277(40):37301-6. PMID: 12163488.
      View in: PubMed
    58. Xu J, Meyers DA, Sterling DA, Zheng SL, Catalona WJ, Cramer SD, Bleecker ER, Ohar J. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):664-9. PMID: 12101115.
      View in: PubMed
    59. Webster KE, Ferree PM, Holmes RP, Cramer SD. Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). Hum Genet. 2000 Aug; 107(2):176-85. PMID: 11030416.
      View in: PubMed
    60. Barreto AM, Schwartz GG, Woodruff R, Cramer SD. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev. 2000 Mar; 9(3):265-70. PMID: 10750664.
      View in: PubMed
    61. Webster KE, Cramer SD. Genetic basis of primary hyperoxaluria type II. Mol Urol. 2000; 4(4):355-64. PMID: 11156703.
      View in: PubMed
    62. Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet. 1999 Oct; 8(11):2063-9. PMID: 10484776.
      View in: PubMed
    63. Peehl DM, Edgar MG, Cramer SD, Deftos LJ. Parathyroid hormone-related protein is not an autocrine growth factor for normal prostatic epithelial cells. Prostate. 1997 Apr 01; 31(1):47-52. PMID: 9108886.
      View in: PubMed
    64. Cramer SD, Chen Z, Peehl DM. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J Urol. 1996 Aug; 156(2 Pt 1):526-31. PMID: 8683730.
      View in: PubMed
    65. Cramer SD, Peehl DM, Edgar MG, Wong ST, Deftos LJ, Feldman D. Parathyroid hormone--related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells. Prostate. 1996 Jul; 29(1):20-9. PMID: 8685051.
      View in: PubMed
    66. Peehl DM, Wong ST, Cramer SD, Gross C, Feldman D. Suramin, hydrocortisone, and retinoic acid modify inhibitory effects of 1,25-dihydroxyvitamin D(3) on prostatic epithelial cells. Urol Oncol. 1995 Sep-Oct; 1(5):188-94. PMID: 21224116.
      View in: PubMed
    67. Krishnan AV, Cramer SD, Bringhurst FR, Feldman D. Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways. Endocrinology. 1995 Feb; 136(2):705-12. PMID: 7835303.
      View in: PubMed
    68. Cramer SD, Wong L, Kensinger RS, Ogren L, Talamantes F. Regulation of the hepatic growth hormone receptor and serum growth hormone-binding protein during pregnancy in the mouse: effects of litter size. Endocrinology. 1992 Dec; 131(6):2914-20. PMID: 1446628.
      View in: PubMed
    69. Cramer SD, Barnard R, Engbers C, Ogren L, Talamantes F. Expression of the growth hormone receptor and growth hormone-binding protein during pregnancy in the mouse. Endocrinology. 1992 Aug; 131(2):876-82. PMID: 1639029.
      View in: PubMed
    70. Cramer SD, Barnard R, Engbers C, Thordarson G, Talamantes F. A mouse growth hormone-binding protein RIA: concentrations in maternal serum during pregnancy. Endocrinology. 1992 Feb; 130(2):1074-6. PMID: 1733707.
      View in: PubMed
    Cramer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (419) concept(s)
    _
    Co-Authors Expand Description
    See all (20) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)